- Home
- HZO vs EVMN Comparison
HZO vs EVMN Comparison
Compare HZO & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HZO | EVMN |
|---|---|---|
| Founded | 1998 | 2020 |
| Country | United States | United States |
| Employees | N/A | 48 |
| Industry | Auto & Home Supply Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 749.0M | 869.1M |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | HZO | EVMN |
|---|---|---|
| Price | $34.48 | $12.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | $30.00 | ★ $43.88 |
| AVG Volume (30 Days) | 266.2K | ★ 1.1M |
| Earning Date | 04-23-2026 | 06-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,309,288,000.00 | N/A |
| Revenue This Year | $3.67 | N/A |
| Revenue Next Year | $4.01 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $21.41 | $12.65 |
| 52 Week High | $38.14 | $33.20 |
Technical Indicators
Market Signals| Indicator | HZO | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 48.26 | 28.50 |
| Support Level | $31.86 | N/A |
| Resistance Level | $36.25 | $20.37 |
| Average True Range (ATR) | 1.53 | 1.75 |
| MACD | -0.07 | -0.98 |
| Stochastic Oscillator | 31.65 | 2.02 |
Price Performance
Historical ComparisonAbout HZO MarineMax Inc. (FL)
MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S and international market.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.